by John Moore | April 13, 2018
At times it can be challenging to draft commentary on all that is happening across this industry sector. Rather than write short posts for each, I have created an amalgamation of commentary to some of the more newsworthy announcements. Roche Acquires Flatiron Wow, whoever knew that data could be such
by Hannah Ehnle | April 03, 2018
This webinar complements the release of our 2018 Population Health Management Market Trends Report. The webinar is presented by the analysts behind the report, Brian Murphy, Matt Guldin and Brian Eastwood. To learn more about the report or to purchase, please click here. Enjoy! To receive the presentation slide deck,
by David Constantine | March 29, 2018
CMS decision removes important barrier for some Medicare cancer patients to access next generation sequencing and companion targeted therapies as well as potential clinical trials. For any new therapy, diagnostic or device brought forth by our healthcare innovation community, there are three high-level barriers generally encountered on the path to
by John Moore lll | February 21, 2018
For those of you who are overwhelmed by looking through the HIMSS18 session schedule (and those of you who have been meaning to look but haven't gotten to it yet), here's Chilmark Research's short list of sessions we expect to be worthwhile, as chosen by our analyst team. It is
by Brian Murphy | February 16, 2018
Key Takeaway PHM products are maturing in spite of uncertainty about payment system. The Chilmark Research 2018 Population Health Management Market Trends Report, long in development, will be released immediately before HIMSS in March. This report profiles 25 vendors and describes the technology landscape for enabling a population health management
by Chilmark Team | December 15, 2017
Our favorite post of the year is this one. As analysts, we come together with our propeller hats on to collectively look ahead at the key trends in the year to come in the healthcare sector. While there are any number of predictions one might make for this dynamic market,
by Chilmark Team | December 11, 2017
In keeping with a Chilmark Research tradition, once again we step into our “way-back machine” to review our 2017 predictions for the healthcare sector - of course with a health IT flavor. Our score is far from perfect, but we did quite well with our 2017 predictions: 7 Hits, 2
by Chilmark Team | October 19, 2017
What a whirlwind it has been – three major conferences for Chilmark Research analysts in three consecutive weeks. Sure, the Epic UGM and Cerner CHC are industry leading events, but our own humble, inaugural event, Convergence, was influential in its own right. Attendees, speakers, and panelists from across the healthcare
